Status:
ACTIVE_NOT_RECRUITING
Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas
Lead Sponsor:
Robert Bosch Medical Center
Conditions:
Persistent Atrial Fibrillation
Catheter Ablation
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
An effective therapy of persistent atrial fibrillation beyond pulmonary vein isolation remains unsatisfactory. Targeting endocardial low-voltage areas represents an approach of substrate modification....
Detailed Description
Pulmonary vein isolation has become the cornerstone of the interventional treatment of paroxysmal atrial fibrillation. For the treatment of persistent atrial fibrillation the data remains unclear. All...
Eligibility Criteria
Inclusion
- Persistent atrial fibrillation according to the current guidelines
- Age \> 18 years
- Patient information
Exclusion
- Minors
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06124690
Start Date
September 1 2023
End Date
September 1 2025
Last Update
December 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Bosch Health Coampus
Stuttgart, Baden-Wurttemberg, Germany, 70197